A CooDerative Studv on ProMACE-dytaBOM in Aggressive Non-Hodgkin's Lymphomas
Edmondo Cassi(University of Milan), Giorgio Lambertenghi‐Deliliers(Ospedale Maggiore), Chiara Butti(University of Milan), L Montalbetti, Luciano Scandolaro(Ospedale Sant'Anna), Paolo Vanoli(University of Milan), Luca Baldini(University of Milan), C Confalonieri, Pietro Pioltelli(University of Milan), Anna Tosi(University of Padua), Franco Lombardi(University of Milan), Enrico Pogliani(Azienda Ospedaliera San Gerardo), Anna Ceriani(University of Milan), Alberto De Paoli(University of Milan), Graziella Pinotti(Medica (Italy)), R. Mozzana(University of Milan), Gianfranco Pavia(University of Milan), Gaetano Brambilla Pisoni(University of Milan)
Cited by 7
Related Papers
Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer
|New England Journal of Medicine|2015|1k
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684